Pinealon
Also known as pineal peptide
Obscure pineal peptide marketed for anti-aging and sleep support with very weak published evidence.
No Human Data
No human exposure data has been identified for this substance. All available evidence comes from animal models or in vitro studies. Safety in humans is completely unknown.
Evidence visual
Pinealon evidence and risk matrix
intermediate researcher fit
Evidence
Tier D
Risk
low
Regulatory
not approved
WADA
none
FDA
unknown
Route
subcutaneous
Weak evidence profile. Treat claims conservatively and compare better-supported alternatives first.
Overview
Pinealon is an obscure short peptide sometimes marketed for sleep, cognition, and anti-aging. Reliable human evidence is effectively absent, and much of the discussion comes from anecdotal or gray-market anti-aging sources rather than validated clinical literature.
Answer first
Pinealon is a weak-evidence research topic, not a first-line sleep or longevity pick.
People usually research Pinealon for sleep, cognition, or anti-aging, but the public evidence base is thin and lacks the kind of reliable human data needed for confident protocol decisions. Treat it as an advanced, speculative compound and compare it against better-supported sleep, cognition, and longevity options before spending money or adding it to a stack.
Nootropic, sleep, pineal, and longevity claims appear in gray-market discussions, but most claims are extrapolated.
No clean dosing standard, no strong human outcome base, and no reliable interaction map for stack planning.
Review DSIP for sleep, Selank for anxiety-focused cognition, and Epitalon for the better-known longevity discussion.
Decision path
Where Pinealon fits in the research path.
Use the evidence and risk profile first, then compare vendors and run the quiz before turning this compound into a protocol decision.
01
Read evidence
02
Check risk
03
Compare options
04
Build plan
Peptide research path
Decide whether Pinealon belongs in your plan.
Use the quiz before choosing a compound, vendor, or PDF. It routes by goal, experience, budget, safety flags, and monitoring comfort.
Research Details
Mechanism is poorly defined; pineal and neuroendocrine signaling claims remain speculative.
subcutaneous
No established human dosing standard exists.
Claims center on sleep and anti-aging support, but meaningful human evidence is absent.
Unknown.
No established human contraindications due to lack of data.
Unknown; product-quality uncertainty may be a larger concern than known intrinsic toxicity.
No documented interaction map.
Cost at a glance
No reliable cycle cost estimate yet. We need cleaner listing price and pack-size data before showing a trustworthy number.
Information provided for educational and research reference only. Not medical advice. Not for diagnosing, treating, curing, or preventing disease. Products referenced are labeled Research Use Only (RUO) by vendors; not for human or veterinary use.
Sources and review notes
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks - U.S. Food and Drug Administration - accessed 2026-05-15
Used for FDA compounding-risk context and peptide safety flags.
- The Prohibited List - World Anti-Doping Agency - accessed 2026-05-15
Used for athlete-facing WADA risk and peptide-class restrictions.
- Peptide therapeutics: current status and future directions - PubMed / Nature Reviews Drug Discovery - accessed 2026-05-15
Used for broad peptide-therapeutics background and evidence framing.
Personalized peptide routing
Find the right path for Pinealon.
Take the quiz before choosing a compound, vendor, or PDF. We match your goal, experience, budget, and monitoring comfort to the next best step in the funnel.
- Goal-matched compound and protocol recommendations.
- Budget and sourcing filters before you leave the site.
- PDF unlocks shown after your personalized result.